• Korea University launched an Injective validator with 369,809 INJ staked, adding an institutional node to the network’s validator set.
  • INJ technical levels in focus were supported at $3.03 and $2.90, while resistance was clustered between $3.39 and $3.60.

Korea University has launched an enterprise validator on the Injective network, with 369,809 INJ already staked, according to an announcement earlier today. The validator is tied to Korea University’s Blockchain Research Institute and expands the university’s role from academic study into live blockchain operations. 

As we previously reported, the move adds an institutional participant to Injective’s validator set.

Korea University is participating in Injective’s transaction verification and network security by operating a validator node. Validators protect the network’s decentralization by maintaining network uptime and consensus. This gives the university an active infrastructure role and gives its research teams direct access to enterprise-level blockchain data.

The latest partnership expands Injective’s presence in the Asia Pacific, a region that other networks like Solana are also targeting, as CNF reported. The collaboration links a university research institute to a blockchain network focused on decentralized financial applications. 

Korea’s #1 University just launched its first-ever enterprise validator on Injective today!

369,809 $INJ is already staked with Korea University as Injective rapidly expands its global reach, now reaching the world’s most prestigious academic institutions. pic.twitter.com/2CHzHZEV3W

— Injective 🥷 (@injective) February 25, 2026

The partnership is structured around applied blockchain research rather than a stand-alone academic program. Korea University and Injective are working on topics tied to real-world asset tokenization, on-chain finance systems, and smart contract security. 

Running a validator creates a path to test technical ideas in a live environment while the network continues normal operations.

Previously, we reported that Canadian mortgage brokerage Pineapple Financial expanded its Injective treasury with a $2 million purchase of 560,647 INJ tokens. The NYSE-listed company said it plans to keep increasing its INJ holdings as part of its treasury strategy.

Injective Validator Operations and Applied Blockchain Research

One of the main aspects of the collaboration is the investigation of MEV-resistant infrastructure and digital assets that will be used in a controlled manner. These are vital to institutions in need of predictable execution, secure smart contract design, and compliance-ready frameworks.

Meanwhile, the INJ price has drawn attention after it went up

1%
to $3.21 from a low of approximately
$3.12
during the day. Technical readings placed the token near lower Bollinger Band support, while RSI around 41 kept momentum in a neutral territory.

Analysts say resistance is around $3.39 to $3.60, with a higher breakout area near $3.63. On the downside, support sits around $3.03, with a stronger support zone near $2.90. The moving average structure still points to a weak trend, although price action near the 20-day average around $3.21 has kept a rebound attempt in sight.

This week, we reported that Injective launched a new Build page to centralize developer resources, including code examples, video tutorials, technical deep dives, AI coding guides, and toolkits.